Cetera Investment Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$275K	Buy	12,763 +931	+8%	+$20.1K	﹤0.01%	3468
2025 Q1	$197K	Buy	+11,832	New	+$197K	﹤0.01%	3613
2024 Q2	–	Sell	-11,559	Closed	-$214K	–	3685
2024 Q1	$214K	Buy	+11,559	New	+$214K	﹤0.01%	3309